Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

In Situ Bioprinting Enhances Bone Regeneration in a Live Animal Model with Craniofacial Defect.

Hindi OA., Pinarbasi B., Bakici M., Demirtas OB., Gokyer S., Buyuksungur A.

Animal Study on Face & Skin, published in ACS Biomater Sci Eng (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
ACS Biomater Sci Eng (2025)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
40704385
PMCID
PMC12344647
DOI
10.1021/acsbiomaterials.5c00780
Citations
3

Abstract (original English)

In situ bioprinting represents an innovative approach in tissue engineering and regenerative medicine, enabling direct deposition of bioinks within the body to create or repair tissues at the target site. This technique leverages advanced bioprinting technologies to deliver cells, biomaterials, and bioactive molecules in a precise, controlled manner, offering the potential for on-demand tissue repair and minimizing the need for extensive surgical intervention. In this research, we apply for the first time in the literature a standard 3D bioprinter to perform in situ bioprinting over the bone defects of live animals under anesthesia and discuss the bone regeneration potential. For this, critical-sized bone defects were created on the parietal bones of the rabbits, followed by the application of autologous adipose-derived stem cell-laden bioink using a 3D bioprinter. Postoperative evaluations included micro-CT and histopathological analysis to assess bone healing and bone-material integration. The results demonstrated successful bone regeneration with the in situ bioprinting approach, as compared to the sham and the use of bioink-only. In conclusion, this study contributes to the growing body of evidence supporting in situ 3D bioprinting as a viable and promising technique for craniofacial bone regeneration, with potential implications for broader clinical relevance and paves the

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsBone RegenerationBioprintingRabbitsPrinting, Three-DimensionalDisease Models, AnimalTissue EngineeringTissue ScaffoldsSkullX-Ray Microtomography

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research